Literature DB >> 3748103

Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model.

B H Weiner, I S Ockene, P H Levine, H F Cuénoud, M Fisher, B F Johnson, A S Daoud, J Jarmolych, D Hosmer, M H Johnson.   

Abstract

We studied the effect of cod-liver oil on the development and progression of coronary artery disease in swine subjected to coronary balloon abrasion and fed an atherogenic diet for eight months. Sections from serial 3-mm segments of the coronary arteries were analyzed morphometrically in 7 pigs given a cod-liver-oil supplement and 11 control animals not given the supplement. Significantly less disease was seen in the sections from the animals fed cod-liver oil. The mean lesion area per vessel, mean luminal encroachment per vessel, and mean maximal luminal encroachment per vessel were reduced in animals fed cod-liver oil, as compared with controls, (P = 0.05, P = 0.016, and P = 0.011, respectively). Both groups of animals had severe hyperlipidemia throughout the study. Differences in the extent of coronary atherosclerosis were not related to differences in plasma lipid levels. Platelet arachidonate was markedly reduced, platelet eicosapentaenoic acid was increased, and serum thromboxane was decreased in the oil-fed group as compared with the control group. We conclude that in our animal mode, dietary cod-liver oil retarded the development of coronary artery disease, possibly through changes in prostaglandin metabolism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3748103     DOI: 10.1056/NEJM198610023151401

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  37 in total

1.  Lipids, atherosclerosis, and restenosis after percutaneous transluminal coronary angioplasty.

Authors:  J J Ferguson; J T Willerson
Journal:  Tex Heart Inst J       Date:  1992

Review 2.  Fatty acid composition of the diet: impact on serum lipids and atherosclerosis.

Authors:  N Zöllner; F Tatò
Journal:  Clin Investig       Date:  1992-11

3.  l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits.

Authors:  Toshio Hayashi; Packiasamy A R Juliet; Hisako Matsui-Hirai; Asaka Miyazaki; Akiko Fukatsu; Jun Funami; Akihisa Iguchi; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

Review 4.  Is there a rational use for n-3 fatty acids (fish oils) in clinical medicine?

Authors:  A Nordøy
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

5.  Accumulation of eicosapentaenoic acid in plasma phospholipids of subjects fed canola oil.

Authors:  E J Corner; V M Bruce; B E McDonald
Journal:  Lipids       Date:  1990-10       Impact factor: 1.880

Review 6.  n-3 fatty acids and lipoproteins: comparison of results from human and animal studies.

Authors:  W S Harris
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

Review 7.  Absorption and transport of fat in mammals with emphasis on n-3 polyunsaturated fatty acids.

Authors:  G J Nelson; R G Ackman
Journal:  Lipids       Date:  1988-11       Impact factor: 1.880

8.  Modulating role of estradiol on arginase II expression in hyperlipidemic rabbits as an atheroprotective mechanism.

Authors:  Toshio Hayashi; Teiji Esaki; Daigo Sumi; Tapan Mukherjee; Akihisa Iguchi; Gautam Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

Review 9.  Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention.

Authors:  L G Spagnoli; A Mauriello; A Orlandi; G Sangiorgi; E Bonanno
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

10.  Comparison of the metabolism of alpha-linolenic acid and its delta 6 desaturation product, stearidonic acid, in cultured NIH-3T3 cells.

Authors:  R C Cantrill; Y S Huang; G W Ells; D F Horrobin
Journal:  Lipids       Date:  1993-03       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.